210 related articles for article (PubMed ID: 30537624)
1. An LC-MS/MS method for quantification of abiraterone, its active metabolites D(4)-abiraterone (D4A) and 5α-abiraterone, and their inactive glucuronide derivatives.
Caron P; Turcotte V; Lévesque E; Guillemette C
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1104():249-255. PubMed ID: 30537624
[TBL] [Abstract][Full Text] [Related]
2. Bioanalytical evaluation of dried plasma spots for monitoring of abiraterone and ∆(4)-abiraterone from cancer patients.
Bhatnagar A; McKay MJ; Thaysen-Andersen M; Arasaratnam M; Crumbaker M; Gurney H; Molloy MP
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Sep; 1126-1127():121741. PubMed ID: 31421381
[TBL] [Abstract][Full Text] [Related]
3. Glucuronidation of Abiraterone and Its Pharmacologically Active Metabolites by UGT1A4, Influence of Polymorphic Variants and Their Potential as Inhibitors of Steroid Glucuronidation.
Vaillancourt J; Turcotte V; Caron P; Villeneuve L; Lacombe L; Pouliot F; Lévesque É; Guillemette C
Drug Metab Dispos; 2020 Feb; 48(2):75-84. PubMed ID: 31727674
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a novel LC-MS/MS method for simultaneous determination of abiraterone and its seven steroidal metabolites in human serum: Innovation in separation of diastereoisomers without use of a chiral column.
Alyamani M; Li Z; Upadhyay SK; Anderson DJ; Auchus RJ; Sharifi N
J Steroid Biochem Mol Biol; 2017 Sep; 172():231-239. PubMed ID: 27063554
[TBL] [Abstract][Full Text] [Related]
5. An LC-MS/MS method for quantification of the active abiraterone metabolite Δ(4)-abiraterone (D4A) in human plasma.
van Nuland M; Rosing H; de Vries J; Ovaa H; Schellens JHM; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Nov; 1068-1069():119-124. PubMed ID: 29059586
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of the anticancer drug abiraterone and its metabolite Δ(4)-abiraterone in human plasma using high-resolution mass spectrometry.
Bhatnagar A; McKay MJ; Crumbaker M; Ahire K; Karuso P; Gurney H; Molloy MP
J Pharm Biomed Anal; 2018 May; 154():66-74. PubMed ID: 29533860
[TBL] [Abstract][Full Text] [Related]
7. A quick UPLC-MS/MS method for therapeutic drug monitoring of abiraterone and delta(4)-abiraterone in human plasma.
Weiss TLD; Furtado CM; Antunes MV; Gössling G; Schwartsmann G; Linden R; Verza SG
Biomed Chromatogr; 2020 Nov; 34(11):e4947. PubMed ID: 32652651
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of dried blood spots as an alternative matrix for therapeutic drug monitoring of abiraterone and delta(4)-abiraterone in prostate cancer patients.
Dillenburg Weiss TL; Gössling G; Venzon Antunes M; Schwartsmann G; Linden R; Gasparin Verza S
J Pharm Biomed Anal; 2021 Feb; 195():113861. PubMed ID: 33373824
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous determination of abiraterone and its five metabolites in human plasma by LC-MS/MS: Application to pharmacokinetic study in healthy Chinese subjects.
Hu Y; Wu J; Jiang X; Chen G; Zhang Y; Si L; Jiang H; Huang J; Huang J
J Pharm Biomed Anal; 2022 Aug; 217():114826. PubMed ID: 35576735
[TBL] [Abstract][Full Text] [Related]
10. Androgen glucuronides analysis by liquid chromatography tandem-mass spectrometry: could it raise new perspectives in the diagnostic field of hormone-dependent malignancies?
Kalogera E; Pistos C; Provatopoulou X; Athanaselis S; Spiliopoulou C; Gounaris A
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 940():24-34. PubMed ID: 24140653
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous quantitation of abiraterone, enzalutamide, N-desmethyl enzalutamide, and bicalutamide in human plasma by LC-MS/MS.
Kim KP; Parise RA; Holleran JL; Lewis LD; Appleman L; van Erp N; Morris MJ; Beumer JH
J Pharm Biomed Anal; 2017 May; 138():197-205. PubMed ID: 28219796
[TBL] [Abstract][Full Text] [Related]
12. Analytical challenges in quantifying abiraterone with LC-MS/MS in human plasma.
Benoist GE; van der Meulen E; Lubberman FJE; Gerritsen WR; Smilde TJ; Schalken JA; Beumer JH; Burger DM; van Erp NP
Biomed Chromatogr; 2017 Nov; 31(11):. PubMed ID: 28370076
[TBL] [Abstract][Full Text] [Related]
13. Determination of Abiraterone and Its Metabolites in Human Serum by LC-ESI-TOF/MS Using Solid-phase Extraction.
Kanji H; Horiyama S; Kimachi T; Haginaka J
Anal Sci; 2021 Sep; 37(9):1281-1287. PubMed ID: 33678729
[TBL] [Abstract][Full Text] [Related]
14. Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapy.
Li Z; Alyamani M; Li J; Rogacki K; Abazeed M; Upadhyay SK; Balk SP; Taplin ME; Auchus RJ; Sharifi N
Nature; 2016 May; 533(7604):547-51. PubMed ID: 27225130
[TBL] [Abstract][Full Text] [Related]
15. Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer.
Li Z; Bishop AC; Alyamani M; Garcia JA; Dreicer R; Bunch D; Liu J; Upadhyay SK; Auchus RJ; Sharifi N
Nature; 2015 Jul; 523(7560):347-51. PubMed ID: 26030522
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of an LC-MS/MS Method for the Simultaneous Quantification of Abiraterone, Enzalutamide, and Their Major Metabolites in Human Plasma.
van Nuland M; Hillebrand MJX; Rosing H; Schellens JHM; Beijnen JH
Ther Drug Monit; 2017 Jun; 39(3):243-251. PubMed ID: 28490047
[TBL] [Abstract][Full Text] [Related]
17. Evaluating bioanalytical capabilities of paper spray ionization for abiraterone drug quantification in patient plasma.
Bhatnagar A; McKay MJ; Arasaratnam M; Crumbaker M; Gurney H; Molloy MP
J Mass Spectrom; 2020 Oct; 55(10):e4584. PubMed ID: 32725840
[TBL] [Abstract][Full Text] [Related]
18. A validated liquid chromatographic-tandem mass spectroscopy method for the quantification of abiraterone acetate and abiraterone in human plasma.
Martins V; Asad Y; Wilsher N; Raynaud F
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Nov; 843(2):262-7. PubMed ID: 16809076
[TBL] [Abstract][Full Text] [Related]
19. Commentary on: "Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapy." Li Z, Alyamani M, Li J, Rogacki K, Abazeed M, Upadhyay SK, Balk SP, Taplin ME, Auchus RJ, Sharifi N. Nature. 2016 May 25;533(7604):547-51.
Lee BH
Urol Oncol; 2017 Sep; 35(9):576. PubMed ID: 28789926
[TBL] [Abstract][Full Text] [Related]
20. Determination of silodosin and its active glucuronide metabolite KMD-3213G in human plasma by LC-MS/MS for a bioequivalence study.
Shah PA; Shrivastav PS
Biomed Chromatogr; 2018 Feb; 32(2):. PubMed ID: 28670733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]